• Wave Life Sciences filed to deregister its Ordinary Shares, ending its U.S. reporting status.
• The filing listed 1 holder of record for the Ordinary Shares as of Aug. 7, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wave Life Sciences Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-340683), on August 10, 2026, and is solely responsible for the information contained therein.